HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines
Pricing decisions and access to pharmaceuticals should be evidence based. Unfortunately, the French guidelines for technology assessment, in their adoption of the National Institute for Health and Clinical Excellence (NICE) reference case modeling standard ensure that this is not the case. Rather t...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2017-01-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/488 |